Congenital heart disease and pulmonary artery hypertension. I. pulmonary vasoreactivity to 15% oxygen before and after surgery  by Waldman, J. Deane et al.
1158 JACC Vol. 2. No 6
December 1983 1158-64
Congenital Heart Disease and Pulmonary Artery Hypertension. I.
Pulmonary Vasoreactivity to 15% Oxygen Before and After Surgery
J. DEANE WALDMAN, MD, FACC,* JOHN J. LAMBERTI, MD, FACC,t
JAMES W. MATHEWSON, MD,* STANLEY E. KIRKPATRICK, MD, FACC,*
SEARLE Wm. TURNER, MD, FACC,* LILY GEORGE, MD,*
STANLEY J. PAPPELBAUM, MD, FACC*
San Diego, California
Pulmonary vasoreactivity at sea level was studied in 22
children before and in 15 children after corrective car-
diac surgery for congenital heart disease and pulmonary
artery hypertension; 8 children were studied both before
and after cardiac surgery. During cardiac catheteriza-
tion in 28 children, pulmonary and systemic hemody-
namics were determined in room air and during breath-
ing of 15% oxygen, which corresponds to a maximal
hypoxic level commonly encountered during airplane
travel.
Before surgery, 19 of 22 children tolerated 15% ox-
ygen (02) , which caused the following hemodynamic
changes from room air status: the ratio of pulmonary
to systemic arterial pressure increased from 0.70 to 0.78
(p < 0.05), the ratio of pulmonary to systemic flow de-
creased from 2.2 to 2.0 (p > 0.05) and the ratio of
pulmonary to systemic vascular resistance increased from
0.33 to 0.40 (p < 0.02). In two children, severe pul-
monary vasoconstriction developed within 5 minutes of
In this study of children with congenital heart disease and
pulmonary artery hypertension, we asked: 1) whether these
patients, because of increased pulmonary artery musculature
(1,2), exhibit an exaggerated pressure response to a hy-
poxic challenge, and 2) whether corrective surgery resulted
in normal pulmonary vasoreactivity, because excessive me-
dial musculature may persist (3).
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15% oxygen administration, requiring immediate dis-
continuation of hypoxia; neither patient had lasting dele-
terious effects. There was no evidence of increased pul-
monary vasoreactivity in children with Down's syndrome
compared with genetically normal children. After cor-
rective surgery in 15 children (including both of the
hyperreactors), no significant pulmonary vascular re-
sponse to 15% oxygen was found.
It is concluded that, in a small number of children
with unrepaired congenital heart disease and pulmonary
artery hypertension, pulmonary vascular hyperreactiv-
ity can be induced by breathing 15% oxygen; this re-
action is life-threatening but reversible with the admin-
istration of 100% oxygen. Air travel without supplemental
oxygen may be dangerous in these patients. It is our
policy to repair the heart defect on an urgent basis when
pulmonary hyperreactivity is found. One year after early
surgery, pulmonary vascular status appears to be nor-
mal even in the hyperreactors.
Methods
Study patients. Twenty-two children were studied be-
fore surgery (Table I). Twelve had perimembranous ven-
tricular septal defect, six had a complete atrioventricular
(AV) canal defect (three with additional patent ductus ar-
teriosus), three had large patent ductus arteriosus and one
had tetralogy of Fallot with pulmonary atresia and a Potts
anastomosis. Median age at study was 13 months (mean 29
months, range 6 months to 19 years). Eleven of the 22
children had trisomy 21. Subsequently, all children under-
went corrective surgery; one (Case 15) died postoperatively.
Fifteen children had postoperative studies (eight of whom
were also evaluated before surgery) (Table 2). In 12 patients,
there was no significant residual heart disease. One child
(Case 19) had severe mitral regurgitation after repair of
complete AV canal defect, one child (Case 26) had a small
leak in the intraatrial baffle after repair of complex trans-
position of the great arteries and one (Case 28) had pul-
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Table 1. Clinical and Hemodynamic Data in 22 Children Before Surgery
PAP/SAP: Qp/Qs: Rp: Rp/Rs:
Age at
Oxygen Oxygen Oxygen Oxygen
ease Diagnosis Down's Study 21% 15% 100% 21% 15% 100% 21% 15% 100% 21% 15% 100%
1 VSD + 6mo 0.73 0.85 2.9 2.0 6.7 10.6 0.24 0.41
2 VSD + 7mo 0.63 0.54 2.0 1.5 4.1 5.3 0.25 0.27
3 VSD + 9mo 0.68 1.00 071 1.6 2.1 4.0 6.3 8.0 0.42 0.44 0.13
4 VSD + limo 0.84 0.79 1.8 1.0 9.8 17.1 0.44 0.74
5 VSD + lyr4mo 037 0.49 2.2 2.6 1.8 3.7 0.12 0.14
6 VSD + lyr5mo 0.73 0.85 0.61 1.5 1.6 6.0 6.9 5.6 1.5 0.41 0.45 0.06
7 VSD 5mo 0.47 0.60 0.52 2.9 2.1 8.5 37 3.4 1.6 0.13 0.19 0.05
8 VSD IOmo 0.50 0.58 0.48 3 I 3.5 5.0 1.7 2.5 1.4 0.15 0.13 0.07
9 VSD 2yrlmo 048 0.39 2.3 2.1 1.9 2.6 0.10 0.10
10 VSD 2yr4mo 0.45 0.62 0.31 22 2.1 5.0 2.5 4.5 0.7 0.19 0.24 0.05
II AVe Iyrlmo 0.42 0.58 4.1 3.2 3.3 5.2 0.11 0.16
12 Ave + lyr3mo 0.88 1.00 0.61 22 2.3 7.5 5.6 7.9 1.6 0.39 0.42 0.07
13 AVe,PDA + 7mo 0.95 1.00 0.86 1 8 I 8 6.7 7.2 9.5 2.6 0.55 0.49 0.11
14 AVe. PDA + 8mo 082 1.00 0.60 22 1.3 5.0 6.4 15.7 1.7 033 0.78 0.11
15 Ave, PDA + 9mo 084 1.00 0.79 1.6 20 4.0 9.0 20.8 5.9 0.52 0.50 019
16 PDA + 6mo 0.87 0.97 2.5 2.2 76 11.7 0.30 0.44
17 PDA 19yr 0.96 0.99 096 24 3.1 4.7 12.4 8.7 6.9 036 0.28 0.18
18 PDA,ASD + 8yr4mo 0.95 0.92 0.83 1.0 10 6.9 13.5 20.8 1.00 0.92 011
19 ASD, small VSD, PDA + lyr2mo 088 0.91 0.82 1.6 1.2 3.6 9.5 22.2 5.0 0.53 0.76 0.22
20 ToF, PA; Potts 7yr2mo 047 060 046 2.2 22 6 I 4.3 47 16 0.14 021 0.05
21 VSD 8mo 0.66 I 12 1.5 9 I 0.34 (1.00)
22 AVe + 6mo 0.90 1.16 066 1 I 7.7 8.8 ., 0.86 (1.00) 0.08
Mean 2yr5mo 0.70 0.78 0.66 22 2.0 5.6 65 9.5 2.8 0.33 0.40 0.11
SD 4yr3mo 020 021 0.19 07 07 1.5 3.4 65 2.1 0.22 0.24 006
P < 0001 NS P < 0.01 P < 0.02
L-p < 002----J L-p < 0.001----J L-p < 0.001----J L-P < 0.001--1
ASD = atnal septal defect, secundum type; AVe = (complete) atnoventncular canal defect; mo = months; PAP/SAP = ratio of pulmonary to
systemic mean artenal pressure; PDA = patent ductus artenosus: Potts = descending aorta to left pulmonary artery anastomosis. Qp/Q~ = ratio of
pulmonary to systemic blood flow. Rp/Rs = ratio of pulmonary to systemic vascular resistance; SD = standard deviation: TGA = transposition of the
great arteries, ToF, PA = tetralogy of Fallot with pulmonary atresia; vSD = ventncular septal defect: yr = years, 21. 15 and 100o/c refer to inhaled
oxygen percentage.
monary vascular obstructive disease. Median age at surgery
was 22 months. and the average length of time between
surgery and postoperative catheterization was 18 months
(median 17. range 4 to 33).
Protocol. The sedative regimen included intramuscular
administration of Innovar (0.02 cc/kg) (droperidol [2.5 mg/
cc] and fentanyl [50 f-tg/ccj) 30 minutes before the study
and ketamine hydrochloride (4 to 5 mg/kg) at entrance to
the catheterization laboratory. Acquisition of hemodynamic
data generally commenced 30 to 45 minutes after the ket-
amine hydrochloride injection. Pressures were measured with
fluid-filled catheters; zero reference was determined by ra-
diographic technique (4). Before surgery. the left atrium
was entered in 18 of 22 patients. In nine patients with a
flap-competent foramen ovale, a fully saturated left atrial
sample in room air was considered representative of pul-
monary venous effluent; a direct pulmonary vein sample
was obtained in those with atrioventricular canal or atrial
septal defect. In the four with intact interatrial septum. sam-
pling at the mitral orifice was considered representative of
pulmonary venous blood. Superior vena cava blood was
used for a mixed venous sample. Informed consent was
obtained from one or both parents in all patients and the
protocol was first approved by the Institutional Review Board
on January 25. 1979.
After study in room air (20.84% oxygen), 14.95% ox-
ygen in nitrogen (hypoxia) was administered via a head
hood. After 5 minutes of hypoxia, a systemic arterial blood
sample was taken to assess blood gas status. Hemodynamic
evaluation was commenced after 10 minutes of spontaneous
respiration of the hypoxic atmosphere. Fourteen of the 22
children were also tested in 100% oxygen; the order was
hypoxia-hyperoxia in 7 and hyperoxia-hypoxia in 7. Be-
tween the two oxygen concentrations. the patient breathed
room air for 5 minutes.
Calculations. Preoperative calculations employed the
Fick principle using an assumed oxygen consumption (VO z)
based on the data of La Farge and Miettinen (5) in those
over 3 years of age; in those younger than 3 years, the
following formula was used: VOz (oxygen consumption) =
([weight in kg x 5.49] + 12.68)/body surface area (rrr')
(Muster AJ. MD, personal communication). Calculations
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Table 2. Clini cal and Hemodynam ic Data in 15 Ch ildren After Surgery
Cardiac Age at
PAP/SAP Rp Rp/R~
Defect Residual Age at Postop
Case Repaired Defectts) Down's Surgery Study 21% 15% 21% 15% 21% 15%
VSD.ASD + lyr2mo 2yr 0.31 0.39 4.0 5,5 0.25 0.41
2 VSD + lyr2mo 2yr7mo 024 0.28 32 2.1 0.17 0. 19
4 VSD + Iyrl mo 2yr2mo 0.32 035 5.7 6.6 030 0 31
5 VSD + lyr6mo 3yr4mo o 15 0.14 1.9 2.4 0. 11 0. 11
9 VSD 2yr5mo 5yr2mo 0.21 0.27 1.8 2.4 0.13 0.17
II AVC lyr3mo 3yr5mo 0.25 0.27 2.4 2.3 0. 12 0. 18
21 VSD IOmo lyr4mo 0.25 0.37 33 5 7 0 17 0.26
22 AVC Resid MR + 7mo 2yr4mo 0.70 0.58 7.2 5.9 0.44 035
23 DORV. PS 10mo lyr2mo 0.28 0.32 3.9 6.8 0.15 0 21
24 VSD 10mo 3yr5mo 0.25 0.29 24 2.6 0. 15 0.17
25 VSD lyrlOmo 3yr3mo 0 24 0.27 3.4 36 0.16 0.18
26 TGA, VSD Atnal baffle lyr5mo 2yr4mo 0.23 0.20 1.4 1 6 008
leak
27 VSD 2yr8mo 4yr7mo 0.16 0.17 1.4 1.6 010 0.10
28 AVC. PS PVOD 9yr4mo IOyr3mo 0.83 0.71 17.2 104
29 AVC + 7mo 2yr2mo 0.24 0.33 5.2 5.7 0.20 0.30
Mean lyrlOmo 3yr4mo 0.31 0.33 4 3 3,9 0.24 0.23
SD lyr4mo 2yr4mo o 19 0. 15 3.9 2.0 0.24 0.09
L-p < 0.02 ....J l-NS---.l l- NS---.l
Patients 23 to 29 not tested preoperatively, DORV = double outlet right ventricle: Postop = postoperative; PS = pulmonary stenosis, PVOD =
pulmonary vascular obstructive disease: Resid MR = residual mitral regurgitation; other abbreviations as In Table I
Average systolic and mean pulmonary artery pressures
were 74.2 ± 17.09 and 45.5 ± 14.7 mm Hg, respectively ,
Figure l. Effect of breath ing 15% O2 on the pulm onary venous
P0 2 in 22 children with congenital hea rt disease and pulmonary
artery hypertension . A decrease is seen in each patient when the
ambient atmosphere is changed from 2 1% O2 (sea level ; room air)
to 15% O2 , Mean P0 2 (..()...) decreased from 85 mm Hg In room
air to 45 mm Hg during hypoxia . Arrows indicate the two
hyperreactors ,
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were performed utilizing oxygen content. Postoperati vely,
cardiac output was measured by thermodilution technique
in 12 of the 15 patient s.
Statistical analysis. Analysis of statistics was based on
the two-ta iled paired t test ; significance was considered at
the less than 0.05 level. For preoperative evaluation , the
effect of hypoxia was primaril y assessed by changes in the
pulmonary to systemic resistance (Rp/Rs) ratio because 1)
a free communication existed between the pulmonary and
systemic circuits; 2) there is no method available to measure
VO~ during 15% oxygen breathing in patients with an in-
tracardiac shunt; and 3) the Rp/Rs ratio is independent of
the VO~ . For postoperative assessment , 13 of the 15children
had no residual shunt and because the two circuits were
separate, absolute pulmonary resistance (measured using
thermod ilution cardiac output ) more accurately reflected
pulmonary vascular status than the Rp/Rs ratio .
Results
Preoperative findings in 20 mildreactors (Table 1). In
Patients I to 20, the average pulmonary venous partial pres-
sure of oxygen (Po-) in room air was 85.4 ± 12.3 mm Hg
(range 60 to 110) in room air and 45.4 ± 9.6 mm Hg (range
38 to 55) during hypoxia (Fig. I ). The change in P02 was
highly significant (probability [p) < 0.00l) . There was no
change in mean arterial partial pressure of carbon dioxide
(Pco -j from room air (41.25 ± 3.62) to 15% oxygen (41.25
± 4.53).
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Figure 2. Effect of 15% O2 on the
ratio of pulmonary to systemic mean
arterial pressure (PAP/SAP) before and
after surgical correction of congenital
heart disease. Left panel, Before sur-
gery in 18 of the 22 children, 15% O2
caused thePAP/SAP ratio to increase
The arrows indicate the two hyper-
reactors (see text) Right panel, After
surgery, most of the 15 children had
a normal PAP/SAP ratio in room air.
The two With persistent elevation of
PAP/SAP had residual mitral regur-
gitation and pulmonary vascular dis-
ease, respectively. In most children.
159'c O2 caused a small but not sig-
nificant increase inthe PAP/SAP ratio.
Arrows again indicate the two hyper-
reactors. both of whom tolerated 15'7r
O2 after surgery.
in room air; hypoxia caused a significant increase in both
of these measurements. Although the hypoxic effect on sys-
tolic systemic arterial pressure was not significant, there
was a significant increase in mean systemic arterial pressure.
A significant (p < 0.001) increase was found in the ratio
of pulmonary to systemic mean pressure (PAP/SAP) from
room air to 15% oxygen (Fig. 2). The net left to right shunt
(Qp/Qs) decreased during hypoxia but the change was not
significant.
Both pulmonary and systemic vascular resistance in-
creased significantly during hypoxia (p < 0.01 and p <
0.05, respectively) (Fig. 3). The magnitude of increase in
pulmonary vascular resistance was greater than the increase
in systemic vascular resistance resulting in a net significant
elevation of the Rp/Rs ratio induced by hypoxia.
Pulmonary vascular response to 15% oxygen in children
with Down's syndrome was compared with the response in
genetically normal children with congenital heart disease,
both in the total preoperative group (Down's 14, normal 8)
and those with ventricular septal defect (Down's 6, normal
4). Comparing average age, PAP/SAP, Qp/Qs and Rp/Rs,
no significant differences were found between patients with
Down's syndrome and the remainder of the group.
One hundred percent oxygen (hyperoxia) was adminis-
tered in 13 of the 20 patients. Hyperoxia caused a small but
significant decrease in pulmonary to systemic artery mean
pressure ratio and a large increase in the left to right shunt.
In 100% oxygen, the ratio of pulmonary to systemic vascular
resistance (Rp/Rs) decreased from 0.33 ± to 0.22 in room
air to 0.11 ± 0.06 (p < 0.005).
Preoperative findings in two hyperreactors (Table 1).
Both patients (Cases 21 and 22) had moderate relative pul-
monary artery hypertension (PAP/SAP 0.66 and 0.90) (Fig.
2) with a small net left to right shunt; one had Down's
syndrome. Hypoxia induced suprasystemic pulmonary ar-
terial pressure within 2 to 4 minutes. As the pulmonary
diastolic pressure increased (Fig. 4), both systemic and pul-
monary systolic pressures began to decrease and the patient
was immediately placed on lOOo/e oxygen. At the time of
suprasystemic pulmonary pressure, profound left atrial hy-
poxemia was noted with P02 values of 20 and 24 mm Hg,
respectively (Fig. I). Shunt calculations were not possible
due to the urgent termination of hypoxia, but the Rp/Rs in
each patient of necessity was greater than 1.00 (Fig. 3).
Postoperative findings in 15 children (Table 2). Eight
of the 15 children were studied both preoperatively and
postoperatively. Thirteen children had no residual intracar-
diac shunt in these children, the systemic arterial blood
sample was considered representative of pulmonary venous
blood. Hypoxia decreased the P02 from 86.7 ± 10.8 mm
Hg in room air to 50.4 ± 7.2 mm Hg. The change in P02
induced by hypoxia postoperatively was not significantly
different from the change noted before surgery (t = 1.660).
One child (Case 26) had a small intraatrial baffle leak with
a Qp/Qs ratio in room air of 0.9. Patient 28 had pulmonary
vascular obstructive disease and a right to left ventricular
shunt (Qp/Qs ratio = 0.6). Flow and resistance calculations
during hypoxia were not made in these two patients.
Most of the 15 children had normal pulmonary artery
pressure in room air: 13 had a mean pressure less than 23
mm Hg; 12 had a PAP/SAP ratio less than 0.30. Although
hypoxia increased mean pulmonary artery pressure in 12
patients, the change was not significant (t = 1.079). The
following measurements were not significantly affected by
hypoxia: mean systemic arterial pressure, ratio of pulmonary
to systemic mean pressures (Fig. 2), absolute pulmonary
vascular resistance (Fig. 3) and ratio of pulmonary to sys-
temic vascular resistance. Both of the preoperative hyper-
reactors (Cases 21 and 22) were studied postoperatively;
each tolerated 15% oxygen without difficulty.
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Figure 3. Effect of breathing 15% O~ on pul-
monary (Rp) and systemic (Rs) vascular resis-
tance before and after surgical correction of con-
genital heart disease. Arrows indicate the two
hyperreactors. Upper left panel, Before sur-
gery, pulmonary vascular resistance increases In
most children during hypoxia (p < 0.01). Quan-
tification of the increased pulmonary vascular
resistance during hypoxia in the two hyperreac-
tors is not possible (question marks). Lower
left panel, Before surgery, pulmonary and sys-
temic vascular resistance both increased during
hypoxia; however, the effect on Rp was greater,
resulting in a significant increase in the Rp/R~
during hypoxia (p < 0.02). The two hyperreac-
torsdeveloped Rp/Rs> 1.00. Upper right panel,
After surgery, most children had normal pul-
monary vascular resistance in both room air and
hypoxia. Hypoxia had no significant effect on
Rp in these children, including the two
hyperreactors.
c-eo 02
21 .. 15 ..
Ambient O 2
Discussion
Previously reported data. Limited data are available
on the pulmonary vascular effects of acute hypoxia in chil-
dren with congenital heart disease. Most prior work has
dealt with the effects of chronic hypoxia, that is, in patients
residing in Denver, Colorado. Blount (6) suggested that the
endemic hypoxia of high altitude living causes increased
medial musculature in the pulmonary resistance vessels.
Vogel, McNamara and Blount (7,8) compared infants with
ventricular septal defect living in Denver with similar infants
living at sea level (Houston); the higher altitude group had
higher pulmonary vascular resistance that was more re-
sponsive to tolazoline. Willerson et al. (9) reported on one
child with ventricular septal defect who had pulmonary ar-
tery hypertension while in Denver but normal pressure when
in Boston. It is clear that the chronic hypoxia of the Denver
atmosphere provides a stimulus to increased pulmonary vas-
cular tone that plays a clinically significant role in children
with unrepaired congenital heart disease (10).
Postoperative hemodynamic studies of the pulmonary
vascular system have been reported from near sea level
(Rochester, Minnesota) as well as Denver. DuShane et al.
(II) at the Mayo Clinic, found normal pulmonary vascular
resistance more than 5 years after surgical repair of ven-
tricular septal defect when the operation was performed in
children under 2 years of age; 7 of the 25 children studied
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Figure 4. Pulmonary and systemic
arterial pressure changes in the two
hyperreactors. Left panel, Patient 22.
Mean pulmonary artery pressure lower
than mean systemic arterial pressure
in room air. becomes suprasysterruc
within 3 minutes of hypoxia admin-
istration. One hundred percent oxygen
causes a profound decrease in the el-
cvated pulmonary artery pressure.
Right panel, Patient 21. Systolic pul-
monary artery pressure is equal to or
lower than left ventricular systolic
pressure in room air; a wide pulmo-
nary artery pulse pressure IS seen. In
hypoxia. systolic pulmonary artery
pressure becomes slightly higher than
systolic left ventricular pressure and
then both begin to decrease: narrowing
of the pulmonary artery pulse width is
evident. Oxygen. IOock. restores the
pressure relations to their prehypoxra
status.
were given 12% oxygen to breathe and each had three or
four units (rrr') of pulmonary vascular resistance. Vogel et
al. (10) in Denver, also found that the Eisenmenger reaction
was rare under 2 years of age. Late postoperative studies
with hypoxic challenge have been reported by Lueker et al.
( 12) from Denver. At cardiac catheterization in 72 patients
over 5 years after repair of atrial septal defect, ventricular
septal defect or patentductus arteriosus. hemodynamic mea-
surements were made in room air and after 4 minutes of
10% oxygen. Abnormal pulmonary vasoreactivity was found
in many patients, even those with normal hemodynamic
values at rest. It was suggested that the excessive medial
musculature persisted in these patients as a result of the
chronic hypoxic stimulus of altitude residence. We are un-
aware of any studies of pulmonary vasoreactivity at sea level
before and after repair of congenital heart disease associated
with pulmonary artery hypertension.
Hemodynamics at sea level: reactors and hyperreac-
tors. Our preoperative patients had pulmonary hyperten-
sion at rest that can be presumed to be secondary to arterial
constriction in response to both volume and pressure over-
load of the pulmonary circuit. Demonstration of increase in
pulmonary blood flow during hypcroxia suggests that the
arterial narrowing was an active muscular phenomenon rather
than fixed obstruction as might be found with scattered
pulmonary emboli or irreversible pulmonary vascular dis-
ease. Hypoxia caused a mild increase in pulmonary pressure
and resistance in the majority of children before surgery.
The degree of change in pulmonary vascular tone was not
related to the level of pulmonary artery hypertension found
in room air.
A striking feature was the exaggerated response to hy-
poxia found in two preoperative patients (Cases 21 and 22)
called hyperreactors: pulmonary resistance became supra-
systemic, pulmonary blood flow acutely decreased and in-
tracardiac right to left shunting increased; coupled with a
decrease in pulmonary venous return, this resulted in ex-
treme hypoxemia. It was clear to the physician performing
the catheterization that the two hyperreactors would have
died if hypoxia had been continued.
The development of suprasystemic pulmonary pressure
is confusing because both children had an interventricular
communication that appeared on angiography to be unre-
strictive, that is, a defect at least equal in size to the aortic
anulus and pressure equalization across the interventricular
septum. Yet, during hypoxia. each developed suprasystemic
pulmonary pressure, a hemodynamic non sequitur. We con-
jecture that the acute clinical deterioration resulted in a
nonsteady state that transiently allowed a hemodynamic
inconsistency.
The two hyperreactors were both under I year of age.
and both had moderately to severely increased pulmonary
artery pressure and resistance with a small net left to right
shunt in room air; one of the two had trisomy 21 . The clinical
and hemodynamic characteristics of the hyperreactors were
similar to those of many of the mild reactors, making it
impossible to predict which patient would be likely to ex-
perience pulmonary vascular hyperreaction.
Patients with Down's syndrome. Down's syndrome may
predispose to early pulmonary vascular disease. In separate
clinical studies, both Chi (13) and Soudan (14) and their
co-workers concluded that the presence of Down's syn-
drome predisposed children with congenital heart disease to
elevated pulmonary vascular resistance. A different conclu-
sion was reached by Wilson et al. (15) in a review of path-
ologic specimens. They concluded that patients with Down's
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syndrome had no propensity for early or severe hypertensive
pulmonary vascular disease. In our preoperative series, half
of the children had Down's syndrome as did one of the two
hyperreactors. No evidence was found for excessive pul-
monary vasoreactivity when those with trisomy 21 were
compared with genetically normal children.
Air travel and pulmonary hypertension. The level of
hypoxia (15% O~) was chosen to correspond to the maximal
hypoxic condition a sea level dweller is likely to encounter,
that is, commercial airplane travel. Whena standard airplane
is fl ying at 11 ,000 to 12,000 meters the cabin altitude is
approximately 2,400 meters (16), which is comparable with
breathing 15% O~ at sea level. It is understood that con-
ditions in the catheterization laboratory are not completely
physiologic (fasting patient who is supine and anesthetized)
and that the hypoxic challenge lasted only 10to 15 minutes.
Also. there are no reported cases of cardiovascular collapse
during flying in patients with congenital heart disease and
pulmonary artery hypertension. However. we consider it
prudent to recommendavoidance of air travel before surgery
in these patients and, if such travel is necessary. to advise
the use of supplemental oxygen.
Surgery and its effects. Prompt corrective surgery may
be warranted in children demonstrating pulmonary vascular
hyperreactivity: the hypoxia-induced phenomenon seen in
the catheterization laboratory may occur under other cir-
cumstances and has been reported in the immediate post-
operative period (17). Furthermore, early surgery appears
more likely to result in normal pulmonary vascular status.
In Boston, Rabinovitch et al. (2) developed a morphometric
quantification of pulmonary vascular changes associated with
congenital heart disease. In patients operated on at or less
than 9 months of age with the most severe (grade C) pul-
monaryvascularchanges, Rabinovitchet al. (personal com-
munication) found normal postoperative hemodynamics in
both room air and 15% O~ . This suggests reversibility of
pulmonary vascular changes if early operation is performed.
Our postoperative data suppo rt the efficacy of early cor-
rective surgery . Of importance is the lack of hyperreaction
after surgery in the two patients who developed life-threat-
ening hypoxic pulmonary vasoconstriction before surgery.
The disparity between our results (normal postoperative pul-
monary vasoreactivity) and those of Lueker et al. (12) (fre-
quent excessive pulmonary vascular reactivity) is probably
related to differences in patient population and study con-
ditions. Comparing our experience with that of Lueker et
al.: I) average age at surgery was 1.8 versus 10.7 years,
respectively; 2) average time from surgery to study was 1.5
versus 4.6 years; 3) a residual left to right shunt was present
in 33% versus none; 4) altitude of residence was 5,000
versus sea level; and 5) hypoxic challenge was 10% oxygen
for 4 minutes versus 15% oxygen for 10 minutes.
Our gratitude IS expressed to James Shibanoff and the staff of the Sharp
Hospital Blood Gas Laboratory for their assistance in this project.
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